1. Wang, Binyang, Fu, Chenyang, Wei, Yuanyuan, Yin, Yong, Qin, Dongdong. 2022. Ferroptosis-related biomarkers for Alzheimer's disease: Identification by bioinformatic analysis in hippocampus. In Frontiers in cellular neuroscience, 16, 1023947. doi:10.3389/fncel.2022.1023947. https://pubmed.ncbi.nlm.nih.gov/36467613/
2. Dias, Marilia M, Adamoski, Douglas, Dos Reis, Larissa M, Ambrosio, Andre Luis Berteli, Dias, Sandra Martha Gomes. 2019. GLS2 is protumorigenic in breast cancers. In Oncogene, 39, 690-702. doi:10.1038/s41388-019-1007-z. https://pubmed.ncbi.nlm.nih.gov/31541193/
3. Velletri, Tania, Romeo, Francesco, Tucci, Paola, Melino, Gerry, Agostini, Massimiliano. 2013. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. In Cell cycle (Georgetown, Tex.), 12, 3564-73. doi:10.4161/cc.26771. https://pubmed.ncbi.nlm.nih.gov/24121663/
4. Beyfuss, Kaitlyn, Hood, David A. 2018. A systematic review of p53 regulation of oxidative stress in skeletal muscle. In Redox report : communications in free radical research, 23, 100-117. doi:10.1080/13510002.2017.1416773. https://pubmed.ncbi.nlm.nih.gov/29298131/
5. Szeliga, Monika, Bogacińska-Karaś, Małgorzata, Kuźmicz, Katarzyna, Rola, Radosław, Albrecht, Jan. 2015. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status. In Molecular carcinogenesis, 55, 1309-16. doi:10.1002/mc.22372. https://pubmed.ncbi.nlm.nih.gov/26258493/
6. Liu, Juan, Zhang, Cen, Lin, Meihua, Hu, Wenwei, Feng, Zhaohui. . Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma. In Oncotarget, 5, 2635-47. doi:. https://pubmed.ncbi.nlm.nih.gov/24797434/
智鼠故事 
